Condition
Pruritus Caused by Drug
Total Trials
4
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
Early P 1 (1)
P 1 (1)
P 3 (1)
P 4 (1)
Trial Status
Recruiting2
Unknown2
Clinical Trials (4)
Showing 4 of 4 trials
NCT07054775Phase 4RecruitingPrimary
Comparison of Pruritus Incidence After Intrathecal Morphine 0.1 vs 0.2 mg in Cesarean Section
NCT06297499Phase 1RecruitingPrimary
Ondansetron Use for Preventing Pruritus in Patients Undergoing Cesarean Section
NCT06243120Early Phase 1UnknownPrimary
Intravenous Lidocaine for Treating Intrathecal Fentanyl Induced Pruritus
NCT06188546Phase 3UnknownPrimary
Propofol for Prophylaxis of Morphine Induced Pruritis in Caesarean Section
Showing all 4 trials